Mirum Pharmaceuticals, Inc. · NASDAQ:MIRM

Peetz Christopher sold 30,000 Mirum Pharmaceuticals, Inc. shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 2, 2026

On Jun 1, 2026, Peetz Christopher (Director, CHIEF EXECUTIVE OFFICER) sold 30,000 Mirum Pharmaceuticals, Inc. shares at an average US$95.84 for US$2.88M under a trading plan, leaving 194,309 shares. Filed Jun 2, 2026 (Form 4).

Sold
30,000 shares
Price
US$95.84 average (US$94.64 to US$99.66)
Value
US$2.88M
Holding after
194,309 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, CHIEF EXECUTIVE OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common StockOption exercise30,000US$2.94224,309Direct
Jun 1, 2026Common StockSale2,602US$94.64221,707Direct
Jun 1, 2026Common StockSale16,595US$95.34205,112Direct
Jun 1, 2026Common StockSale6,926US$96.15198,186Direct
Jun 1, 2026Common StockSale1,973US$97.56196,213Direct
Jun 1, 2026Common StockSale1,021US$98.20195,192Direct
Jun 1, 2026Common StockSale883US$99.66194,309Direct

Source

View original at SEC

Related